1 of an insulin antagonist from the urine of patients with lipoatrophic diabetes has been reported. It also was demonstrated that a similar substance was present in the urine of a maturity-onset insulin-resistant diabetic without lipoatrophy. The substance was found to be a polypeptide which when administered to either dogs or man exhibited diabetogenic and anti-insulin effects. The origin of the active principle had not been determined. The present report describes a procedure for the isolation of a similar substance from the anterior lobes of bovine pituitary glands. Like the insulin antagonist from the urine, the material is also highly active both in dogs and in man.
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LOUIS, CONN AND MINICK
PREPARATION OF FRACTION PI
Fig.
1A
oxycellulose powder (17-21 per cent COOH, Eastman Chemical Products, Inc., Kingsport, Tennessee) employed in step 4 was kept refrigerated and before use was washed successively with distilled water, 0.1 N HCL, and distilled water. Electrophoresis of fraction PI on cellulose acetate reveals 3 bands, a prominent one with minor bands before and after. Elemental analysis of the compound gives the following; C 48.32 per cent, H 7.18 per cent, N 15.36 per cent, and S 1.41 per cent. Its isoelectric point is approximately pH 4.1, and the average yield is 0.05-0.06 per cent. Dogs were maintained on a constant high carbohydrate diet (454 Cm. of Pard and 75 Gm. of glucose) and the human subjects on a constant 3.200 calorie diet including 300 Gm. of carbohydrate before and during all testing procedures. Glucose and insulin tolerance tests were carried out before and at various intervals after administration of the material, Twentyfour hour urine specimens were collected daily on the human subjects for the estimation of 17-ketosteroids,s I7-hydroxysteroids,4 uric acid,5 glucose,a and creatinine.7 The active principle from the pituitary tissue was prepared for injection in exactly the same way as that previously described* for the insulin antagonist extracted from urine. 
RESULTS
Fraction
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Fraction PI also induces glucose intolerance and insulin resistance in man. Tables 1, 2 and 3 show the results obtained when 20 mg. was administered intramuscularly in a single dose to each of 3 normal volunteers. In each case the largest degree of carbohydrate intolerance was observed 8 hours following administration of PI. Table 4 shows that urinary excretion of 17-hydroxysteroids, 17-ketosteroids and uric acid did not change significantly.
Insulin tolerance tests were performed on 2 more healthy subjects. This time doses of 20 and 30 mg. of fraction PI were administered intramuscularly on 2 successive days and the insulin tolerance tests were done 9 and 33 hours after the second injection. Although fraction PIIIC2 is a hydrolytic product of fraction PI, it possesses diabetogenic and anti-insulin properties. However, in one set of experiments on the same dog (Fig. 7, 8 and 9 ), fraction PI was found to be approximately twice as potent as fraction PIIICB.
Biological activity of fraction PIIIC2 was tested on 7 normal young men. Three of them received a single dose of 11-12 mg. intramuscularly and all developed glucose intolerance. Figures 10 and 11 show the results of subjects W. M. B. and J. S. S. Table 5 indicates that urinary excretion of 17-hydroxysteroids, 17-ketosteroids, and uric acid did not change significantly.
Each of the other 4 subjects was given a larger single dose (40 mg.) of the 
DISCUSSION
A diabetogenic polypeptide has been isolated from bovine adenohypophsis by the same procedure with which a similar diabetogenic polypeptide was previously isolated from the urine of patients with lipoatrophic diabetes.2 The physical properties of both compounds are very similar and have isoelectric points at approximately pH 4.1. Mild acid hydrolysis of both polypeptides yields a similar active substance which in both cases has an isoelectric point at approximately pH 4.7. The material is not bovine corticotropin since no evidence of adrenal cortical stimulation was observed. Pure bovine growth hormone does not diminish carbohydrate tolerance of man .8 It has been shown that bovine growth hormone can be altered by chemical manipulation after which it may induce carbohydrate intolerance in man .9 While this possibility exists, it seems an unlikely one since the isolation procedure employed in our work for the isolation of fraction PI is sufficiently mild that one would not anticipate disruption of the growth hormone molecule.* Furthermore, the prolonged reduction in 
